Please login to the form below

annual results

This page shows the latest annual results news and features for those working in and with pharma, biotech and healthcare.

Vertex's two-drug cystic fibrosis treatment cleared in US

It will start shipping the product in the US later this week with an annual price of $292, 000, a little higher than the list price for Orkambi. ... Vertex’chief executive Jeff Leiden said during the company’s annual results meeting that it

Latest news

Bayer: Post-truth politics severely handicaps innovation

Both are "reasons for concern", given the importance of "reliable and innovation-friendly conditions in our markets", he told a press briefing on the company's annual results at its headquarters
Xarelto and Eylea continue to dominate Bayer's pharma sales

The company estimates that six of them - in the mid- to late-stage pipeline - have an estimated combined peak annual sales potential of at least 6bn.".
GSK and J&J move closer to sirukumab filing for arthritis

Results presented at this week's Annual European Congress of Rheumatology (EULAR 2016) in London, UK, showed that sirukumab slowed down the progressive joint destruction in RA and improved the symptoms
Boehringer Ingelheim returns to growth after US turnaround

Prof Andreas Barner at Boehringer's annual press conference in Germany. Boehringer Ingelheim made a return to growth last year after sales rose 11% to 14.8bn, largely thanks to a ... Unveiling the results at Boehringer's annual conference in Ingelheim,
Pfizer's PCSK9 inhibitor clears another phase III trial

Pfizer has reported positive phase III trial results with its cholesterol-lowering candidate bococizumab, setting up a possible regulatory filing in the coming months. ... products in their recent annual results statements.

More from news
Approximately 0 fully matching, plus 43 partially matching documents found.

Latest Intelligence

Doing more with less: when ‘client-centricity’ matters most

The Edelman Trust Barometer is all about earning trust. We often use our annual survey results to inform client programmes. ... In 2018, results found the most trusted ‘voices. of authority’to be technical and academic experts.
Can value-based healthcare take off and reach for the skies?

Ahmad, speaking at a satellite session at the company’s annual results conference earlier this year, revealed that 10% of hospital Trusts in England have contracts with Novartis which is leading
Strategic planning: a state of flux

We see many marketers going through the familiar drill of filling in brand templates and presenting the results at the ‘annual review’- but in some cases it’s simply viewed as
Case study: Treatment guidance

The Practical Guide was launched as part of a Takeda sponsored symposium at the British Sarcoma Group’ s annual conference. ... launched. Takeda’ s KAM team distributed the guide to HCPs throughout the UK and at the British Oncology Pharmacy
Case study: Treatment guidance

The Practical Guide was launched as part of a Takeda sponsored symposium at the British Sarcoma Group’ s annual conference. ... launched. Takeda’ s KAM team distributed the guide to HCPs throughout the UK and at the British Oncology Pharmacy

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

How to get faster results with digital communication

How to get faster results with digital communication. Everyone is under pressure to deliver results fast, so how can you speed up the positive effects of your e-detailing and multichannel ... Everyone is under pressure to deliver results fast, so how can

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Market Access Consultant - Greater Manchester: Negotiable

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Systematic Review Lead- London: Negotiable

Account Manager- 4 days per week or full-time: Salary TBC

Sudler London - Account Director: Competitive

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Senior Account Manager – Healthcare Advertising: Salary TBC

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Medical Writers Required - Hertfordshire: Competitive

Senior Medical Writer: Salary is DOE

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Sudler London - Senior Medical Writer: Competitive

Senior Medical Writer, MedComms Agency: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Medical Writer - Creative and Scientific Projects: DOE

Account Director, Healthcare Advertising Agency: Salary TBC

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....